ClinConnect ClinConnect Logo
Search / Trial NCT05596253

Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis

Launched by WEST CHINA HOSPITAL · Oct 23, 2022

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how often heart failure occurs in patients with liver cirrhosis who undergo a procedure called transjugular intrahepatic portosystemic shunt (TIPS). TIPS is a treatment that helps improve blood flow in the liver. The study aims to find out who is more likely to develop heart failure after this procedure and to learn about any factors that could affect heart function in these patients.

To participate in the trial, individuals must have cirrhosis and successfully have a TIPS procedure done. They also need to agree to join the study. However, people with certain conditions, such as severe heart or lung problems, or those who have had a TIPS before, are not eligible. Participants in the trial can expect to be monitored closely for signs of heart failure and may undergo various tests to help researchers gather important information. This study is currently looking for volunteers and hopes to shed light on the heart health of patients with cirrhosis after undergoing TIPS.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Cirrhosis
  • 2. TIPS is placed successfully
  • 3. Agree to participate in the trial
  • Exclusion Criteria:
  • 1. Non-cirrhotic portal hypertension
  • 2. Previous TIPS or surgical shunt
  • 3. Medium to severe pulmonary hypertension
  • 4. Heart failure
  • 5. End-stage renal disease requiring hemodialysis
  • 6. Respiratory failure
  • 7. Malignancies with a life expectancy of less than 6 months

About West China Hospital

West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.

Locations

Chengdu, , China

Chengdu, Sichuan, China

Patients applied

0 patients applied

Trial Officials

xuefeng luo

Principal Investigator

Sichuan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials